{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T20:40:34Z","timestamp":1783629634662,"version":"3.55.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ischemia\/reperfusion injury contributes to periprocedural myocardial injury (PMI) in patients undergoing percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). PMI can be estimated by the elevation of troponin (Tn) and creatine kinase-MB (CKMB) plasma levels, and it is associated with increased risk of cardiovascular events and mortality. Vitamin C might have a beneficial effect on PMI by improving endothelial function, improving myocardial perfusion, and by reducing oxidative stress generated during\/after reperfusion. In several small animal models of cardiac stress, vitamin C reduced the increase in Tn and CKMB levels. The aim of this meta-analysis was to investigate whether vitamin C administration may have an effect on Tn and CKMB levels in patients undergoing PCI or CABG.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We searched PubMed, Cochrane, Embase and Scopus databases for controlled clinical trials reporting on Tn and CKMB levels in adult patients who underwent PCI or CABG and received vitamin C. As secondary outcomes we collected data on biomarkers of oxidative stress in the included trials. In our meta-analysis, we used the relative scale and estimated the effect as the ratio of means.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found seven controlled trials which included 872 patients. All included trials administered vitamin C intravenously, with a range from 1 to 16\u00a0g\/day, and all initiated vitamin administration prior to the procedure. Vitamin C decreased peak Tn plasma levels in four trials on average by 43% (95% CI: 13 to 63%, p\u2009=\u20090.01) and peak CKMB plasma levels in five trials by 14% (95% CI: 8 to 21%, p\u2009&lt;\u20090.001). Vitamin C also significantly decreased the biomarkers of oxidative stress.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Vitamin C may decrease cardiac enzyme levels in patients undergoing elective PCI or CABG. This may be explained partially by its antioxidant effects. Our findings encourage further research on vitamin C administration during cardiac procedures and in other clinical contexts that increase the level of cardiac enzymes. Future studies should search for an optimal dosing regimen, taking baseline and follow-up plasma vitamin C levels into account.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-023-03459-6","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T11:01:59Z","timestamp":1695294119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Vitamin C may reduce troponin and CKMB levels after PCI and CABG: a meta-analysis"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1185-4373","authenticated-orcid":false,"given":"Sander","family":"Rozemeijer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4710-307X","authenticated-orcid":false,"given":"Harri","family":"Hemil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlinde","family":"van Baaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8738-8295","authenticated-orcid":false,"given":"Ang\u00e9lique M.E.","family":"de Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"issue":"3","key":"3459_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jjcc.2020.03.008","volume":"76","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Chen Z, Ma J, Chen A, Lu D, Wu Y, et al. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention. J Cardiol. 2020;76(3):309\u201316.","journal-title":"J Cardiol"},{"issue":"13","key":"3459_CR2","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/eurheartj\/ehx799","volume":"39","author":"M Zeitouni","year":"2018","unstructured":"Zeitouni M, Silvain J, Guedeney P, Kerneis M, Yan Y, Overtchouk P, et al. Periprocedural myocardial infarction and injury in elective coronary stenting. Eur Heart J. 2018;39(13):1100\u20139.","journal-title":"Eur Heart J"},{"issue":"27","key":"3459_CR3","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1093\/eurheartj\/ehab271","volume":"42","author":"H Bulluck","year":"2021","unstructured":"Bulluck H, Paradies V, Barbato E, Baumbach A, B\u00f8tker HE, Capodanno D, et al. Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2021;42(27):2630\u201342.","journal-title":"Eur Heart J"},{"issue":"31","key":"3459_CR4","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1093\/eurheartj\/ehx383","volume":"38","author":"M Thielmann","year":"2017","unstructured":"Thielmann M, Sharma V, Al-Attar N, Bulluck H, Bisleri G, Bunge J, et al. ESC Joint Working Groups on Cardiovascular surgery and the Cellular Biology of the heart position paper: Perioperative myocardial injury and infarction in patients undergoing coronary artery bypass graft surgery. Eur Heart J. 2017;38(31):2392\u2013407.","journal-title":"Eur Heart J"},{"issue":"5","key":"3459_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1056\/NEJMra0912134","volume":"364","author":"A Prasad","year":"2011","unstructured":"Prasad A, Herrmann J. Myocardial infarction due to percutaneous coronary intervention. N Engl J Med. 2011;364(5):453\u201364.","journal-title":"N Engl J Med"},{"issue":"1","key":"3459_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S0735-1097(98)00551-8","volume":"33","author":"BE Tardiff","year":"1999","unstructured":"Tardiff BE, Califf RM, Tcheng JE, Lincoff AM, Sigmon KN, Harrington RA, et al. Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II investigators. Integrilin (eptifibatide) to minimize platelet aggregation and coronary Thrombosis-II. J Am Coll Cardiol. 1999;33(1):88\u201396.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"3459_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.ehj.2003.12.009","volume":"25","author":"MT Roe","year":"2004","unstructured":"Roe MT, Mahaffey KW, Kilaru R, Alexander JH, Akkerhuis KM, Simoons ML, et al. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes. Eur Heart J. 2004;25(4):313\u201321.","journal-title":"Eur Heart J"},{"issue":"9","key":"3459_CR8","first-page":"648","volume":"16","author":"H Asci","year":"2016","unstructured":"Asci H, Saygin M, Yesilot S, Topsakal S, Cankara FN, Ozmen O, et al. Protective effects of aspirin and vitamin C against corn syrup consumption-induced cardiac damage through sirtuin-1 and HIF-1alpha pathway. Anatol J Cardiol. 2016;16(9):648\u201354.","journal-title":"Anatol J Cardiol"},{"issue":"2","key":"3459_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.21608\/ajfm.2016.18319","volume":"27","author":"A Wahdan","year":"2016","unstructured":"Wahdan A, Shareef M. Study of the Protective effect of vitamin C on Monosodium Glutamate Induced Cardiotoxicity in Adult male albino rats. Ain Shams Journal of Forensic Medicine and Clinical Toxicology. 2016;27(2):49\u201356.","journal-title":"Ain Shams Journal of Forensic Medicine and Clinical Toxicology"},{"issue":"1","key":"3459_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1139\/cjpp-2014-0336","volume":"93","author":"MM Abdel-Daim","year":"2015","unstructured":"Abdel-Daim MM, Ghazy EW, Fayez M. Synergistic protective role of mirazid (Commiphora molmol) and ascorbic acid against tilmicosin-induced cardiotoxicity in mice. Can J Physiol Pharmacol. 2015;93(1):45\u201351.","journal-title":"Can J Physiol Pharmacol"},{"issue":"10","key":"3459_CR11","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3109\/10715762.2011.605361","volume":"45","author":"T Okazaki","year":"2011","unstructured":"Okazaki T, Otani H, Shimazu T, Yoshioka K, Fujita M, Iwasaka T. Ascorbic acid and N-acetyl cysteine prevent uncoupling of nitric oxide synthase and increase tolerance to ischemia\/reperfusion injury in diabetic rat heart. Free Radic Res. 2011;45(10):1173\u201383.","journal-title":"Free Radic Res"},{"issue":"9","key":"3459_CR12","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.freeradbiomed.2004.06.041","volume":"37","author":"VH Guaiquil","year":"2004","unstructured":"Guaiquil VH, Golde DW, Beckles DL, Mascareno EJ, Siddiqui MA. Vitamin C inhibits hypoxia-induced damage and apoptotic signaling pathways in cardiomyocytes and ischemic hearts. Free Radic Biol Med. 2004;37(9):1419\u201329.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"3459_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/0003-4975(89)90431-1","volume":"47","author":"DA Mickle","year":"1989","unstructured":"Mickle DA, Li RK, Weisel RD, Birnbaum PL, Wu TW, Jackowski G, et al. Myocardial salvage with trolox and ascorbic acid for an acute evolving infarction. Ann Thorac Surg. 1989;47(4):553\u20137.","journal-title":"Ann Thorac Surg"},{"issue":"17","key":"3459_CR14","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1089\/ars.2013.5205","volume":"19","author":"JM May","year":"2013","unstructured":"May JM, Harrison FE. Role of vitamin C in the function of the vascular endothelium. Antioxid Redox Signal. 2013;19(17):2068\u201383.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"3459_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.atherosclerosis.2014.04.004","volume":"235","author":"AW Ashor","year":"2014","unstructured":"Ashor AW, Lara J, Mathers JC, Siervo M. Effect of vitamin C on endothelial function in health and disease: a systematic review and meta-analysis of randomised controlled trials. Atherosclerosis. 2014;235(1):9\u201320.","journal-title":"Atherosclerosis"},{"issue":"2","key":"3459_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jcin.2009.10.025","volume":"3","author":"S Basili","year":"2010","unstructured":"Basili S, Tanzilli G, Mangieri E, Raparelli V, Di Santo S, Pignatelli P, et al. Intravenous ascorbic acid infusion improves myocardial perfusion grade during elective percutaneous coronary intervention: relationship with oxidative stress markers. JACC Cardiovasc Interv. 2010;3(2):221\u20139.","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"3459_CR17","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00421-011-1997-x","volume":"112","author":"Z Gao","year":"2012","unstructured":"Gao Z, Spilk S, Momen A, Muller MD, Leuenberger UA, Sinoway LI. Vitamin C prevents hyperoxia-mediated coronary vasoconstriction and impairment of myocardial function in healthy subjects. Eur J Appl Physiol. 2012;112(2):483\u201392.","journal-title":"Eur J Appl Physiol"},{"issue":"5","key":"3459_CR18","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1152\/japplphysiol.00595.2006","volume":"102","author":"PH McNulty","year":"2007","unstructured":"McNulty PH, Robertson BJ, Tulli MA, Hess J, Harach LA, Scott S, et al. Effect of hyperoxia and vitamin C on coronary blood flow in patients with ischemic heart disease. J Appl Physiol. 2007;102(5):2040\u20135.","journal-title":"J Appl Physiol"},{"key":"3459_CR19","doi-asserted-by":"publisher","first-page":"789729","DOI":"10.3389\/fcvm.2022.789729","volume":"9","author":"H Hemil\u00e4","year":"2022","unstructured":"Hemil\u00e4 H, Chalker E, de Man AME. Vitamin C may improve left ventricular ejection fraction: a Meta-analysis. Front Cardiovasc Med. 2022;9:789729.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"3459_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12872-017-0478-5","volume":"17","author":"H Hemil\u00e4","year":"2017","unstructured":"Hemil\u00e4 H, Suonsyrj\u00e4 T. Vitamin C for preventing atrial fibrillation in high risk patients: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2017;17(1):49.","journal-title":"BMC Cardiovasc Disord"},{"key":"3459_CR21","doi-asserted-by":"crossref","unstructured":"Cowled P, Fitridge R. Pathophysiology of Reperfusion Injury. In: Fitridge R, Thompson M, editors. Mechanisms of vascular disease: a reference book for vascular specialists [Internet]: Adelaide (AU). University of Adelaide Press; 2011.","DOI":"10.1017\/UPO9781922064004"},{"issue":"3","key":"3459_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.cardiores.2003.10.025","volume":"61","author":"LB Becker","year":"2004","unstructured":"Becker LB. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res. 2004;61(3):461\u201370.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"3459_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/s13054-014-0460-x","volume":"18","author":"HM Oudemans-van Straaten","year":"2014","unstructured":"Oudemans-van Straaten HM, Spoelstra-de Man AM, de Waard MC. Vitamin C revisited. Crit Care. 2014;18(4):460.","journal-title":"Crit Care"},{"issue":"1","key":"3459_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00380-010-0029-9","volume":"26","author":"MD Bagatini","year":"2011","unstructured":"Bagatini MD, Martins CC, Battisti V, Gasparetto D, da Rosa CS, Spanevello RM, et al. Oxidative stress versus antioxidant defenses in patients with acute myocardial infarction. Heart Vessels. 2011;26(1):55\u201363.","journal-title":"Heart Vessels"},{"issue":"2","key":"3459_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/bja\/aeg042","volume":"90","author":"A Lassnigg","year":"2003","unstructured":"Lassnigg A, Punz A, Barker R, Keznickl P, Manhart N, Roth E, et al. Influence of intravenous vitamin E supplementation in cardiac surgery on oxidative stress: a double-blinded, randomized, controlled study. Br J Anaesth. 2003;90(2):148\u201354.","journal-title":"Br J Anaesth"},{"issue":"6","key":"3459_CR26","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.nut.2013.10.026","volume":"30","author":"S Rodemeister","year":"2014","unstructured":"Rodemeister S, Duquesne M, Adolph M, Nohr D, Biesalski HK, Unertl K. Massive and long-lasting decrease in vitamin C plasma levels as a consequence of extracorporeal circulation. Nutrition. 2014;30(6):673\u20138.","journal-title":"Nutrition"},{"issue":"1","key":"3459_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13054-018-1996-y","volume":"22","author":"AME Spoelstra-de Man","year":"2018","unstructured":"Spoelstra-de Man AME, Elbers PWG, Oudemans-van Straaten HM. Making sense of early high-dose intravenous vitamin C in ischemia\/reperfusion injury. Crit Care. 2018;22(1):70.","journal-title":"Crit Care"},{"issue":"2","key":"3459_CR28","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jcin.2009.12.003","volume":"3","author":"P Delafontaine","year":"2010","unstructured":"Delafontaine P, Anwar A. Vitamin C and percutaneous coronary intervention. JACC Cardiovasc Interventions. 2010;3(2):230\u20132.","journal-title":"JACC Cardiovasc Interventions"},{"key":"3459_CR29","unstructured":"Higgins JPT, Savovi\u0107 J, Page MJ, Elbers RG, Sterne JAC. Chapter 8: assessing risk of bias in a randomized trial 2021. Available from: www.training.cochrane.org\/handbook."},{"issue":"5","key":"3459_CR30","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.jclinepi.2010.09.016","volume":"64","author":"JO Friedrich","year":"2011","unstructured":"Friedrich JO, Adhikari NKJ, Beyene J. Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods. J Clin Epidemiol. 2011;64(5):556\u201364.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"3459_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.cjca.2013.08.018","volume":"30","author":"ZJ Wang","year":"2014","unstructured":"Wang ZJ, Hu WK, Liu YY, Shi DM, Cheng WJ, Guo YH, et al. The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention. Can J Cardiol. 2014;30(1):96\u2013101.","journal-title":"Can J Cardiol"},{"issue":"1","key":"3459_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14(1):135.","journal-title":"BMC Med Res Methodol"},{"issue":"8","key":"3459_CR33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/003655101753267982","volume":"61","author":"GL Oktar","year":"2001","unstructured":"Oktar GL, Sinci V, Kalaycioglu S, Soncul H, G\u00f6kg\u00f6z L, Halit V, et al. Biochemical and hemodynamic effects of ascorbic acid and alpha-tocopherol in coronary artery surgery. Scand J Clin Lab Invest. 2001;61(8):621\u20139.","journal-title":"Scand J Clin Lab Invest"},{"issue":"5","key":"3459_CR34","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1055\/s-2007-1016504","volume":"42","author":"H Dingchao","year":"1994","unstructured":"Dingchao H, Zhiduan Q, Liye H, Xiaodong F. The protective effects of high-dose ascorbic acid on myocardium against reperfusion injury during and after cardiopulmonary bypass. Thorac Cardiovasc Surg. 1994;42(5):276\u20138.","journal-title":"Thorac Cardiovasc Surg"},{"key":"3459_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-21416-0","volume-title":"Meta-analysis with R","author":"G Schwarzer","year":"2015","unstructured":"Schwarzer G, Carpenter JR, Rucker G. Meta-analysis with R. London: Springer; 2015."},{"key":"3459_CR36","unstructured":"R Project for Statistical Computing. Available from: https:\/\/www.r-project.org."},{"issue":"4","key":"3459_CR37","doi-asserted-by":"publisher","first-page":"319","DOI":"10.38053\/acmj.982137","volume":"3","author":"Y G\u00fcltekin","year":"2021","unstructured":"G\u00fcltekin Y, G\u00fczel A, Karakaya A, Be\u015fo\u011ful Y. Combined effects of the implementation of magnesium and ascorbic acid on myocardial ischemia-reperfusion in open heart surgery. Anatol Curr Med J. 2021;3(4):319\u201326.","journal-title":"Anatol Curr Med J"},{"key":"3459_CR38","unstructured":"Hemil\u00e4 H. G\u00fcltekin (2021) paper has a substantial number of identical data with the 20-year earlier Demirag (2001) paper. Pubpeer 2022 Feb. Available from: https:\/\/pubpeer.com\/publications\/8150B66EC0289FA4BF7C9ADB1C48A9#1."},{"issue":"10","key":"3459_CR39","first-page":"29","volume":"18","author":"AR Rostami","year":"2016","unstructured":"Rostami AR, Sharifi M, Kamali AR, Kalantari M. Evaluation of the effect of combination of N-Acetylcysteine and vitamin C on improving outcomes following CABG. J Arak Univ Med Sci. 2016;18(10):29\u201339.","journal-title":"J Arak Univ Med Sci"},{"issue":"2","key":"3459_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4103\/jrpp.JRPP_18_78","volume":"8","author":"N Shafaei-Bajestani","year":"2019","unstructured":"Shafaei-Bajestani N, Talasaz AH, Salarifar M, Pourhosseini H, Sadri F, Jalali A. Potential role of vitamin C Intracoronary Administration in preventing Cardiac Injury after primary percutaneous coronary intervention in patients with ST-Elevation myocardial infarction. J Res Pharm Pract. 2019;8(2):75\u201382.","journal-title":"J Res Pharm Pract"},{"issue":"5","key":"3459_CR41","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2174\/1573401315666190712213051","volume":"16","author":"J Moludi","year":"2020","unstructured":"Moludi J, Alizadeh M, Chehri G, Jafari-Vayghyan H, Foroumandi E, Maleki V, et al. The effect of vitamin C supplementation on cardiac enzymes after coronary artery bypass graft: a double-blind Randomized Control Trial. Curr Nutr Food Sci. 2020;16(5):833\u20138.","journal-title":"Curr Nutr Food Sci"},{"key":"3459_CR42","unstructured":"Hemil\u00e4 H. Statistical problems in the vitamin C trial with PCI patients by Shafaei-Bajestani. (2019). Pubpeer 2022 Feb. Available from: https:\/\/pubpeer.com\/publications\/1B59AD863839D55215841C1124C2D3#1."},{"key":"3459_CR43","unstructured":"Hemil\u00e4 H. Statistical problems in the vitamin C trial with CABG patients by Moludi. (2020). Pubpeer 2022 Feb. Available from: https:\/\/pubpeer.com\/publications\/2E9E504061A7DC2AF6B2692D8632F1#1."},{"key":"3459_CR44","doi-asserted-by":"crossref","unstructured":"Antonic M, Lipovec R, Gregorcic F, Juric P, Kosir G. Perioperative ascorbic acid supplementation does not reduce theincidence of postoperative atrial fibrillation in on-pump coronary artery bypass graft patients. J Cardiol. 2017;69(1):98\u2013102.","DOI":"10.1016\/j.jjcc.2016.01.010"},{"issue":"1","key":"3459_CR45","first-page":"67","volume":"16","author":"K Demirag","year":"2001","unstructured":"Demirag K, Askar FZ, Uyar M, Cevik A, Ozmen D, Mutaf I, et al. The protective effects of high dose ascorbic acid and diltiazem on myocardial ischaemia-reperfusion injury. Middle East J Anaesthesiol. 2001;16(1):67\u201379.","journal-title":"Middle East J Anaesthesiol"},{"issue":"7644","key":"3459_CR46","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","volume":"336","author":"L Wood","year":"2008","unstructured":"Wood L, Egger M, Gluud LL, Schulz KF, J\u00fcni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ. 2008;336(7644):601.","journal-title":"BMJ"},{"issue":"18","key":"3459_CR47","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.3390\/molecules26185702","volume":"26","author":"R Rodrigo","year":"2021","unstructured":"Rodrigo R, Prieto JC, Aguayo R, Ramos C, Puentes \u00c1, Gajardo A, et al. Joint cardioprotective effect of vitamin C and other antioxidants against Reperfusion Injury in patients with Acute Myocardial Infarction undergoing percutaneous coronary intervention. Molecules. 2021;26(18):5702.","journal-title":"Molecules"},{"issue":"5","key":"3459_CR48","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1097\/00005344-200105000-00008","volume":"37","author":"GR Ellis","year":"2001","unstructured":"Ellis GR, Anderson RA, Chirkov YY, Morris-Thurgood J, Jackson SK, Lewis MJ, et al. Acute effects of vitamin C on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failure. J Cardiovasc Pharmacol. 2001;37(5):564\u201370.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"3459_CR49","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S0002-8703(03)00184-4","volume":"146","author":"S Erbs","year":"2003","unstructured":"Erbs S, Gielen S, Linke A, M\u00f6bius-Winkler S, Adams V, Baither Y, et al. Improvement of peripheral endothelial dysfunction by acute vitamin C application: different effects in patients with coronary artery disease, ischemic, and dilated cardiomyopathy. Am Heart J. 2003;146(2):280\u20135.","journal-title":"Am Heart J"},{"issue":"4","key":"3459_CR50","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/01.CIR.97.4.363","volume":"97","author":"B Hornig","year":"1998","unstructured":"Hornig B, Arakawa N, Kohler C, Drexler H. Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. Circulation. 1998;97(4):363\u20138.","journal-title":"Circulation"},{"issue":"6510","key":"3459_CR51","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0140-6736(48)90572-8","volume":"251","author":"-C Vitamin","year":"1948","unstructured":"Vitamin -C. Requirement of human adults experimental study of vitamin-C deprivation in man: a preliminary report by the vitamin C subcommittee of the accessory food factors committee, medical research council. The Lancet. 1948;251(6510):853\u20138.","journal-title":"The Lancet"},{"issue":"5","key":"3459_CR52","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1056\/NEJM197001292820519","volume":"282","author":"S Sament","year":"1970","unstructured":"Sament S. Cardiac disorders in scurvy. N Engl J Med. 1970;282(5):282\u20133.","journal-title":"N Engl J Med"},{"issue":"7508","key":"3459_CR53","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0140-6736(67)90004-9","volume":"290","author":"J Shafar","year":"1967","unstructured":"Shafar J. Rapid reversion of electrocardiographic abnormalities after treatment in two cases of scurvy. The Lancet. 1967;290(7508):176\u20138.","journal-title":"The Lancet"},{"key":"3459_CR54","first-page":"409","volume":"5","author":"L Eddy","year":"1990","unstructured":"Eddy L, Hurvitz R, Hochstein P. A protective role for ascorbate in induced ischemic arrest associated with cardiopulmonary bypass. J Appl Cardiol. 1990;5:409\u201314.","journal-title":"J Appl Cardiol"},{"issue":"2","key":"3459_CR55","first-page":"182","volume":"24","author":"P Devanandan","year":"2020","unstructured":"Devanandan P, Puvvada RC, Muthukumar VA. Effects of vitamin C supplementation on the glycemic control and cardiovascular risk in type II diabetes Mellitus. J Res Pharm. 2020;24(2):182\u20137.","journal-title":"J Res Pharm"},{"issue":"4","key":"3459_CR56","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1177\/147323001003800436","volume":"38","author":"JY Lee","year":"2010","unstructured":"Lee JY, Kim CJ, Chung MY. Effect of high-dose vitamin C on oxygen free radical production and myocardial enzyme after tourniquet ischaemia-reperfusion injury during bilateral total knee replacement. J Int Med Res. 2010;38(4):1519\u201329.","journal-title":"J Int Med Res"},{"issue":"3","key":"3459_CR57","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/ALN.0000000000004117","volume":"136","author":"C Holse","year":"2022","unstructured":"Holse C, Aasvang EK, Vester-Andersen M, Rasmussen LS, Wetterslev J, Christensen R, et al. Hyperoxia and Antioxidants for Myocardial Injury in Noncardiac Surgery: A 2 \u00d7 2 Factorial, Blinded, Randomized Clinical Trial. Anesthesiology. 2022;136(3):408\u201319.","journal-title":"Anesthesiology"},{"issue":"18","key":"3459_CR58","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1001\/jama.2008.600","volume":"300","author":"HD Sesso","year":"2008","unstructured":"Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians\u2019 Health Study II randomized controlled trial. JAMA. 2008;300(18):2123\u201333.","journal-title":"JAMA"},{"issue":"10","key":"3459_CR59","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1161\/01.CIR.0000028146.71416.2E","volume":"106","author":"SG Ellis","year":"2002","unstructured":"Ellis SG, Chew D, Chan A, Whitlow PL, Schneider JP, Topol EJ. Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy. Circulation. 2002;106(10):1205\u201310.","journal-title":"Circulation"},{"issue":"5","key":"3459_CR60","doi-asserted-by":"publisher","first-page":"517","DOI":"10.21470\/1678-9741-2018-0312","volume":"34","author":"N Emadi","year":"2019","unstructured":"Emadi N, Nemati MH, Ghorbani M, Allahyari E. The effect of high-dose vitamin C on biochemical markers of myocardial Injury in Coronary artery bypass surgery. Braz J Cardiovasc Surg. 2019;34(5):517\u201324.","journal-title":"Braz J Cardiovasc Surg"},{"issue":"2","key":"3459_CR61","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3945\/an.110.000109","volume":"2","author":"M Levine","year":"2011","unstructured":"Levine M, Padayatty SJ, Espey MG. Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries. Adv Nutr. 2011;2(2):78\u201388.","journal-title":"Adv Nutr"},{"issue":"7","key":"3459_CR62","doi-asserted-by":"publisher","first-page":"533","DOI":"10.7326\/0003-4819-140-7-200404060-00010","volume":"140","author":"SJ Padayatty","year":"2004","unstructured":"Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140(7):533\u20137.","journal-title":"Ann Intern Med"},{"issue":"6","key":"3459_CR63","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/odi.12446","volume":"22","author":"SJ Padayatty","year":"2016","unstructured":"Padayatty SJ, Levine M, Vitamin C. The known and the unknown and Goldilocks. Oral Dis. 2016;22(6):463\u201393.","journal-title":"Oral Dis"},{"issue":"1","key":"3459_CR64","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s13054-021-03670-x","volume":"25","author":"S Rozemeijer","year":"2021","unstructured":"Rozemeijer S, van der Horst FAL, de Man AME. Measuring vitamin C in critically ill patients: clinical importance and practical difficulties-Is it time for a surrogate marker? Crit Care. 2021;25(1):310.","journal-title":"Crit Care"},{"issue":"1","key":"3459_CR65","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40635-021-00403-w","volume":"9","author":"S Rozemeijer","year":"2021","unstructured":"Rozemeijer S, Smit B, Elbers PWG, Girbes ARJ, Oudemans-van Straaten HM, de Man AME. Rapid screening of critically ill patients for low plasma vitamin C concentrations using a point-of-care oxidation\u2013reduction potential measurement. Intensive Care Medicine Experimental. 2021;9(1):40.","journal-title":"Intensive Care Medicine Experimental"},{"key":"3459_CR66","unstructured":"Dietary Reference Intakes for, Vitamin C, Vitamin E, Selenium. and Carotenoids.: Washington (DC): National Academies Press (US); 2000 [5:Vitamin C]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK225480\/."},{"issue":"7","key":"3459_CR67","doi-asserted-by":"publisher","first-page":"e11414","DOI":"10.1371\/journal.pone.0011414","volume":"5","author":"SJ Padayatty","year":"2010","unstructured":"Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J, Levine M, Vitamin C. Intravenous use by complementary and alternative medicine practitioners and adverse Effects. PLoS ONE. 2010;5(7):e11414.","journal-title":"PLoS ONE"},{"issue":"25","key":"3459_CR68","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa2200644","volume":"386","author":"F Lamontagne","year":"2022","unstructured":"Lamontagne F, Masse M-H, Menard J, Sprague S, Pinto R, Heyland DK, et al. Intravenous vitamin C in adults with Sepsis in the Intensive Care Unit. N Engl J Med. 2022;386(25):2387\u201398.","journal-title":"N Engl J Med"},{"issue":"4","key":"3459_CR69","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41430-022-01254-8","volume":"77","author":"H Hemil\u00e4","year":"2023","unstructured":"Hemil\u00e4 H, Chalker E. Abrupt termination of vitamin C from ICU patients may increase mortality: secondary analysis of the LOVIT trial. Eur J Clin Nutr. 2023;77(4):490\u20134.","journal-title":"Eur J Clin Nutr"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03459-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03459-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03459-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T16:11:47Z","timestamp":1700410307000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03459-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3459"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03459-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"assertion":[{"value":"14 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Grant of the Netherlands Organisation for Health Research and Development for the VITaCCA trial () for A.M.E. de Man and S. Rozemeijer. The other authors do not have any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"475"}}